Immunocytochemical monitoring of micrometastatic disease: Reduction of prostate cancer cells in bone marrow by androgen deprivation

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 521-525

  Pantel, Klaus ^a   Enzmann, Thomas ^b   Köllermann, Jens ^c   Caprano, Jörg ^b   Riethmüller, Gert ^a   Köllermann, Manfred W ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Praxis Nuklearmed am Stadt Klin   (Germany)

^c Insiitut f Pathol der Stadt K   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; FLUTAMIDE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW METASTASIS; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONITORING; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FLUTAMIDE; FOLLOW-UP STUDIES; HUMANS; KERATINS; LEUPROLIDE; MALE; NEOPLASM PROTEINS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0030927099     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<521::AID-IJC4>3.0.CO;2-W     Document Type: Article

References (31)

1. COTE, R.J., BEATTIE, E.J., CHAIWUN, B., SHI, S.R., HARVEY, J., CHEN, S.C., SHERROD, A.E., GROSHEN, S. and TAYLOR, S.R., Detection of occult bone marrow micronietastases in patients with operable lung carcinoma. Ann. Surg.,222, 415-423 (1995).
2. COTE, R.J., ROSEN, P.P., LESSER, M.L., OLD, L.J. and OSBORNE, M.P., Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol.,9, 1749-1756 (1991).
3. DALESIO, O., Complete androgen blockade in prostate cancer: an overview of randomized trials. Prostate, 4 (Suppl.), 111-114 (1992).
4. DIEL, I.J., KAUFMANN, M., GOERNER, R., COSTA, S.D., KAUL, S. and BASTBRT, G., Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J. Clin. Oncol.,10, 1534-15391 (1992).
5. FAIR, W.R., ISRAELI, R.S, and WANG, Y., Neoadjuvant androgen-deprivation therapy (ADT) prior to radical prpstatectomy results in a significantly decreased incidence of residual micrometastatic disease as detected by nested RT-PCR with PSM primer. Proc. Amer. Urol. Ass.,153, 391A (1995).
6. FUCHS, E., Keratins as biochemical markers of epithelial differentiation. Trends Genet.,4, 277-281 (1988).
7. GRIWATZ, C., BRANDT, B., ASSMANN, G. and ZÄNKER, K.S., An immunological enrichment method for epithelial cells from peripheral blood. J. Immunol. Methods. 183, 251-265 (1995).
8. HARBECK, N., UNTCH, M., FACHE, L. and EIERMANN, W., Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Brit. J. Cancer, 69, 566-571 (1994).
9. HEISS, M.M., ALLCAYER, H., GRUETZNER, K.U., FUNKE, I., BABIC, R., JAUCH, K.-W. and SCHILDBERG, F.W., Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow. A reference to early systemic disease in solid cancer. Nature (Med.), 1, 1035-1039 (1995).
10. HODGE, K.K., MCNEAL, J.E. and STAMEV, T.A., Ultrasound guided transrectal core biopsies of the palpably abnormal prostate, J. Urol.,142, 66-70 (1989).
11. HSIEH, J.-T., ZHAU, H.E., WANG, X.-H., LIEW, C-C. and CHUNG, L.W.K., Regulation of basal and luminal cell-specific cytokeratin expression in rat accessory sex organs. J. biol. Chem.,267, 2303-2310 (1992).
12. JAUCH, K., HEISS, M.M., GRÜTZNER, U., FUNKE, I., PANTEL, K., BABIC, R., EISSNER, H.J., RIETHMÜLLER, G. and SCHILDBERG, F.W., Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J. Clin. Oncol.,14, 1810-1817 (1996).
13. KRISMANN, M., TODT, B. and SCHRÖDER, J., Low specificity of cytokeratin 19 reverse transeriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol.,13, 2769-2775 (1995).
14. LINDEMANN, F., SCHLIMOK, G., DIRSCHEDL, P., WITTE, J. and RIETHMÜLLER, G., Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet, 340, 685-689 (1992).
15. LIOTTA, L.A., KLEINERMAN, J. and SAIDEL, G.M., Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res.,34, 997-1004 (1974).
16. MANSI, J.L., EASTON, D., BERGER, U., GAZET, J.C., FORD, H.T., DEARNALEY, D. and COOMBES, R.C., Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Europ. J. Cancer, 27, 1552-1555 (1991).
17. MILLER, J.I., AHMANN, P.R. and DRACH, G.W., The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastastic prostate cancer. J. Urol.,147, 956-961 (1992).
18. MYKLEBVIST, A., GODAL, A., JUELL, S., PHARO, A. and FODSTAD, O., Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow. Cancer Res.,54, 209-214 (1994).
19. OBERNEDER, R., RIESENBERG, R., KRIEGMAIR, M., BITZER, U., KLAMMERT, R., SCHNEEDE, P., HOFSTETTER, A., RIETHMÜLLER, G. and PANTEL, K., Immunocytochemical detection, and phenotypic characterization of micrometastatic tumor cells in bone marrow of patients with prostate cancer. Urol. Res.,22, 3-8 (1994).
20. PANTEL, K., AIGNHERR, C., KÖLLERMANN, J., CAPRANO, J., RIETHMÜLLER, G. and KÖLLERMANN, M.W., Immunocytochemical detection of isolated tumor cells in bone marrow of patients with untreated stage C prostatic cancer. Europ. J. Cancer, 31A, 1627-1632 (1995a).
21. PANTEL, K., DICKMANNS, A., ZIPPELIUS, F., KLEIN, C., SHI, J., HOECHTLEN-VOLLMAR, W., SCHLIMOK, G., WECKERMANN, D., OBERNEDER, R., FANNING, E. and RLETHMÜLLER, G., Establishment of carcinoma cell lines from bone marrow of patients with minimal residual cancer: a novel source of tumor cell vaccines. J. nat. Concer Inst.,87, 1162-1168 (1995b).
22. PANTEL, K., IZBICKI, J., PASSLICK, B., ANGSTWURM, M., HÄUSSINGER, K., THETTER, O. and RIETHMÜLLER, G., Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet, 347, 649-653 (1996).
23. PANTEL, K., SCHLIMOK, G., ANGSTWURM, M., WECKERMANN, C., SCHMAUS, W., GATH, H., PASSLICK, B., IZBICKI, J. and RIETHMÜLLER, G., Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother.,3, 165-173 (1994).
24. PANTEL, K., SCHLIMOK, G., BRAUN, S., KUTTER, D., SCHALLER, G., FUNKE, I., IZBICKI, J. and RIETHMÜLLER, G., Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. nat. Cancer Inst.,85, 1419-1424 (1993).
25. PANTEL, K., SCHLIMOK, G., KUTTER, D., SCHALLER, G., GENZ, T., WIEBECKE, B., BACKMANN, R., FUNKE, I. and RIETHMÜLLER, G., Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res.,51, 4712-4715 (1991).
26. RIESENBERG, R., OBERNEDER, R., KRIEGMAIR, M., EPP, M., BITZER, L.J., HOFSTETTER, A., BRAUN, S., RIETHMÜLLER, G. and PANTEL, K., Immunocy-toehemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells. Histochemistry, 99, 61-66 (1993).
27. SCHLIMOK, G., FUNKE, I., PANTEL, K., STROBEL, F., LINDEMANN, F., WITTE, J. and RIETHMÜLLER, G., Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Europ. J. Cancer, 27, 1461-1465 (1991).
28. SCHLIMOK, G., PANTEL, K., LOIBNER, H., FACKLER-SCHWALBE, I. and RIETHM ÜLLER, G., Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody, towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Europ. J. Cancer, 31 A, 1799-1803 (1995).
29. SMITH, M.R., BIGGAK, S. and HUSSAIN, M., Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res.,55, 2640-2644 (1995).
30. THORBAN, S., RODER, J.D., NEKARDA, H., FUNK, A., SIEWERT, J.R. and PANTEL, K., Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J. nat. Cancer Inst.,88, 1228-1233 (1996).
31. ZIPPELIUS, A., HONOLD, G., KUFER, P., SCHLIMOK, G., RIETHMÜLLER, G. and PANTEL, K., Potential and limitations of RT-PCR for detection of isolated carcinoma cells in bone marrow [Abstract]. Exp. Hematol.,23, 763 (1995).